1.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CDR0000068686, ISIS-3521-CS17, CWRU-040123, ISIS-1501, NCT00017407
|
|
2.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NABTT-9706, JHOC-NABTT-9706
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: ECOG-3197, NCT00003236, E3197
|
|
4.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: CAN-NCIC-IND111, IND111
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: CAN-NCIC-IND112, IND112
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: EORTC-16977, ISIS-EORTC-16977, NCT00003989
|
|
7.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-000808401, ISIS-3521-CS18, NCI-G02-2056
|